Accumulation of α-synuclein triggered by presynaptic dysfunction

Journal of Neuroscience

Volumn 32, Issue 48, 2012, Pages 17186-17196

  Nakata, Yasuto ^a   Yasuda, Toru ^a,b   Fukaya, Masahiro ^a   Yamamori, Saori ^a   Itakura, Makoto ^a   Nihira, Tomoko ^a   Hayakawa, Hideki ^a   Kawanami, Aya ^a   Kataoka, Masakazu ^c   Nagai, Makiko ^a   Sakagami, Hiroyuki ^a   Takahashi, Masami ^a   Mizuno, Yoshikuni ^a   Mochizuki, Hideki ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; NEUROTRANSMITTER; SNARE PROTEIN; SYNAPTOBREVIN 2; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; VESICULAR GLUTAMATE TRANSPORTER 1;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEMENTIA; DOPAMINERGIC NERVE CELL; FEMALE; FERTILIZATION IN VITRO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOELECTRON MICROSCOPY; LEWY BODY; MALE; MOUSE; NONHUMAN; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYNAPTOSOME; WESTERN BLOTTING;

ALPHA-SYNUCLEIN; ANIMALS; CORPUS STRIATUM; LEWY BODIES; MICE; MICE, TRANSGENIC; NEURONS; PARKINSON DISEASE; PRESYNAPTIC TERMINALS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 84870231777     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2220-12.2012     Document Type: Article

References (60)

1. Asuni AA, Cunningham C, Vigneswaran P, Perry VH, O'Connor V (2008) Unaltered SNARE complex formation in an in vivo model of prion disease. Brain Res 1233:1-7.
2. Bamford NS, Robinson S, Palmiter RD, Joyce JA, Moore C, Meshul CK (2004) Dopamine modulates release from corticostriatal terminals. J Neurosci 24:9541-9552.
3. Burgoyne RD, Morgan A (2011) Chaperoning the SNAREs: a role in preventing neurodegeneration? Nat Cell Biol 13:8-9.
4. Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Südhof TC (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663-1667.
5. Cabin DE, Shimazu K, Murphy D, Cole NB, Gottschalk W, McIlwain KL, Orrison B, Chen A, Ellis CE, Paylor R, Lu B, Nussbaum RL (2002) Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking α-Synuclein. J Neurosci 22:8797-8807.
6. Chandra S, Gallardo G, Fernandez-Chacon R, Schlüüter OM, Südhof TC (2005) Alpha-synuclein cooperates with CSPalpha in preventing neuro degeneration. Cell 123:383-396.
7. Chung CY, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuro-inflammation precede dopaminergic neuronal loss in a rat model of AAV α-Synucleinopathy. J Neurosci 29:3365-3373.
8. Chung YH, Joo KM, Kim MJ, Cha CI (2003) Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation. Neurosci Lett 342:151-154.
9. Darios F, Ruiperez V, Lopez I, Villanueva J, Gutierrez LM, Davletov B (2010) Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep 11:528-533.
10. Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates, Ed 3. New York: Academic.
11. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T (2002) Alpha-Synuclein is phosphory-lated in synucleinopathy lesions. Nat Cell Biol 4:160-164.
12. Furuya T, Hayakawa H, Yamada M, Yoshimi K, Hisahara S, Miura M, Mizuno Y, Mochizuki H (2004) Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 24:1865-1872.
13. Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58:186-190.
14. Garcia-Reitbock P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E, Ghetti B, Della Corte L, Spano P, Tofaris GK, Goedert M, Spillantini MG (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain 133:2032-2044.
15. Gerfen CR, Surmeier DJ (2011) Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34:441-466.
16. Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM (2010) Memory Impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci 30:6367-6374.
17. Gureviciene I, Gurevicius K, Tanila H (2007) Role of alpha-synuclein in synaptic glutamate release. Neurobiol Dis 28:83-89.
18. Haucke V, Neher E, Sigrist SJ (2011) Protein scaffolds in the coupling of synaptic exocytosis and endocytosis. Nat RevNeurosci 12:127-138.
19. Hayes NVL, Baines AJ (1996) Small synaptic vesicles. In: Biomembranes: a multi-volume treatise (Lee AG, ed), pp 75-122. Greenwich, CT: JAI.
20. Herzig MC, Kolly C, Persohn E, Theil D, Schweizer T, Hafner T, Stemmelen C, Troxler TJ, Schmid P, Danner S, Schnell CR, Mueller M, Kinzel B, Grevot A, Bolognani F, Stirn M, Kuhn RR, Kaupmann K, van der Putten PH, Rovelli G, et al. (2011) LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 20:4209-4223.
21. Hu K, Carroll J, Rickman C, Davletov B (2002) Action of Complexin on SNARE complex. J Biol Chem 277:41652-41656.
22. Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T (1995) The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14:467-475.
23. Iwasaki S, Kataoka M, Sekiguchi M, Shimazaki Y, Sato K, Takahashi M (2000) Two distinct mechanisms underlie the stimulation of neurotransmitter release by phorbol esters in clonal rat pheochromocytoma PC12 cells. J Biochem 128:407-414.
24. Kataoka M, Yamamori S, Suzuki E, Watanabe S, Sato T, Miyaoka H, Azuma S, Ikegami S, Kuwahara R, Suzuki-Migishima R, Nakahara Y, Nihonmatsu I, Inokuchi K, Katoh-Fukui Y, Yokoyama M, Takahashi M (2011) A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouse. PLoS One 6:e25158.
25. Kaushal N, Seminerio MJ, Shaikh J, Medina MA, Mesangeau C, Wilson LL, McCurdy CR, Matsumoto RR (2011) CM156, a high affinity sigma li-gand, attenuates the stimulant and neurotoxic effects of methamphet-amine in mice. Neuropharmacology 61:992-1000.
26. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M (2006) The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26:2991-3001.
27. Kramer ML, Schulz-Schaeffer WJ (2007) Presynaptic α-Synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 27:1405-1410.
28. Kuwahara T, Koyama A, Koyama S, Yoshina S, Ren CH, Kato T, Mitani S, Iwatsubo T (2008) A systematic RNAi screen reveals involvement of en-docytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. Elegans. Hum Mol Genet 17:2997-3009.
29. Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Edwards RH, Stefanis L, Sulzer D (2006) α-Synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci 26:11915-11922.
30. Majewski H, Iannazzo L (1998) Protein kinase C: a physiological mediator of enhanced transmitter output. Prog Neurobiol 55:463-475.
31. Maroteaux L, Campanelli JT, Scheller RH (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci 8:2804-2815.
32. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alz-heimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 98: 12245-12250.
33. McFarland MA, Ellis CE, Markey SP, Nussbaum RL (2008) Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. Mol Cell Proteomics 7:2123-2137.
34. Miyazaki T, Fukaya M, Shimizu H, Watanabe M (2003) Subtype switching of vesicular glutamate transporters at parallel fibre-Purkinje cell synapses in developing mouse cerebellum. Eur J Neurosci 17:2563-2572.
35. Morgan A, Burgoyne RD, Barclay JW, Craig TJ, Prescott GR, Ciufo LF, Evans GJ, Graham ME (2005) Regulation of exocytosis by protein kinase C. Biochem Soc Trans 33:1341-1344.
36. Morgan JR, Prasad K, Hao W, Augustine GJ, Lafer EM (2000) A conserved clathrin assembly motif essential for synaptic vesicle endocytosis. J Neurosci 20:8667-8676.
37. Murphy DD, Rueter SM, Trojanowski JQ, Lee VM (2000) Synucleins are developmentally expressed, and α-Synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci 20: 3214-3220.
38. Nagy G, Matti U, Nehring RB, Binz T, Rettig J, Neher E, Sørensen JB (2002) Protein kinase C-dependent phosphorylation of synaptosome-associated protein of 25 kDa at Ser187 potentiates vesicle recruitment. J Neurosci 22:9278-9286.
39. Nemani VM, Lu W, Berge V, Nakamura K, Onoa B, Lee MK, Chaudhry FA, Nicoll RA, Edwards RH (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle recluster-ing after endocytosis. Neuron 65:66-79.
40. Neumann M, Kahle PJ, Giasson BI, Ozmen L, Borroni E, Spooren W, Müller V, Odoy S, Fujiwara H, Hasegawa M, Iwatsubo T, Trojanowski JQ, Kretz-schmar HA, Haass C (2002) Misfolded proteinase K-resistant hyper-phosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J Clin Invest 110: 1429-1439.
41. Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 131:642-650.
42. Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762.
43. Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62:644-654.
44. Sakisaka T, Yamamoto Y, Mochida S, Nakamura M, Nishikawa K, Ishizaki H, Okamoto-Tanaka M, Miyoshi J, Fujiyoshi Y, Manabe T, Takai Y (2008) Dual inhibition of SNARE complex formation by tomosyn ensures controlled neurotransmitter release. J Cell Biol 183:323-337.
45. Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol 120:131-143.
46. Scott DA, Tabarean I, Tang Y, Cartier A, Masliah E, Roy S (2010) A pathologic cascade leading to synaptic dysfunction in α-Synuclein-induced neurodegeneration. J Neurosci 30:8083-8095.
47. Sharma M, Burre J, Südhof TC (2011) CSPalpha promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. Nat Cell Biol 13:30-39.
48. Shimazaki Y, Nishiki T, Omori A, Sekiguchi M, Kamata Y, Kozaki S, Takahashi M (1996) Phosphorylation of 25-kDa synaptosome-associated protein. Possible involvement in protein kinase C-mediated regulation of neurotransmitter release. J Biol Chem 271:14548-14553.
49. Shoji-Kasai Y, Itakura M, Kataoka M, Yamamori S, Takahashi M (2002) Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur J Neurosci 15:1390-1394.
50. Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16-27.
51. Südhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27:509-547.
52. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Südhof TC (2007) A Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318:71-76.
53. Tapia-González S, Giráldez-Pérez RM, Cuartero MI, Casarejos MJ, Mena MA, Wang XF, Sánchez-Capelo A (2011) Dopamine and alpha-synuclein dysfunction in Smad3 null mice. Mol Neurodegener 6:72.
54. Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive su-pranuclear palsy: a comparative investigation. Brain 133:172-188.
55. Ubhi K, Low P, Masliah E (2011) Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 34:581-590.
56. Wickens JR, Arbuthnott GW (2005) Structural and functional interactions in the striatum at the receptor level. In: Dopamine, Handbook of Chemical Neuroanatomy, Vol 21 (Dunnett SB, Bentivoglio M, Bjorklund A, Hokfelt T, eds), pp 199-236. Amsterdam: Elsevier.
57. Yamamori S, Itakura M, Sugaya D, Katsumata O, Sakagami H, Takahashi M (2011) Differential expression of SNAP-25 family proteins in the mouse brain. J Comp Neurol 519:916-932.
58. Yasuda T, Hayakawa H, Nihira T, Ren YR, Nakata Y, Nagai M, Hattori N, Miyake K, Takada M, Shimada T, Mizuno Y, Mochizuki H (2011) Parkin-mediated protection of dopaminergic neurons in a chronic MPTP-minipump mouse model of Parkinson disease. J Neuropathol Exp Neurol 70:686-697.
59. Yasuda T, Nakata Y, Mochizuki H (2012) α-Synuclein and neuronal cell death. Mol Neurobiol. Advance online publication. Retrieved November 8, 2012. doi:10.1007/s12035-012-8327-0.
60. Yoshida M (2007) Multiple system atrophy: α-Synuclein and neuronal degeneration. Neuropathology 27:484-493.